| 0 |
ALPHA 1 FOETOPROTEIN AMNIOTIC FLUID DECREASED |
1 |
1.0000 |
| 1 |
HEPATIC HYPOPERFUSION |
1 |
0.1429 |
| 2 |
VAGINAL FLATULENCE |
33 |
0.1089 |
| 3 |
NASAL OEDEMA |
191 |
0.1056 |
| 4 |
CONJUNCTIVAL RETRACTION |
1 |
0.0625 |
| 5 |
RESPIRATORY PARALYSIS |
9 |
0.0563 |
| 6 |
BARREL CHEST |
1 |
0.0526 |
| 7 |
LARYNGEAL TREMOR |
1 |
0.0476 |
| 8 |
GRAFT VERSUS HOST DISEASE IN INTESTINE |
5 |
0.0385 |
| 9 |
ENDOTOXAEMIA |
1 |
0.0385 |
| 10 |
FAMILIAL HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
1 |
0.0323 |
| 11 |
CEMENTOPLASTY |
1 |
0.0312 |
| 12 |
INTESTINAL HYPOMOTILITY |
1 |
0.0294 |
| 13 |
BACILLUS BACTERAEMIA |
3 |
0.0275 |
| 14 |
DISSEMINATED SPOROTRICHOSIS |
1 |
0.0263 |
| 15 |
CHOLANGITIS INFECTIVE |
7 |
0.0263 |
| 16 |
HEPATIC VEIN OCCLUSION |
4 |
0.0253 |
| 17 |
SUPERINFECTION FUNGAL |
2 |
0.0235 |
| 18 |
FLAVOBACTERIUM INFECTION |
1 |
0.0227 |
| 19 |
CAROTID PULSE DECREASED |
1 |
0.0222 |
| 20 |
TRICHOSPORON INFECTION |
9 |
0.0222 |
| 21 |
LEUKAEMIC INFILTRATION PULMONARY |
1 |
0.0217 |
| 22 |
EWING'S SARCOMA |
1 |
0.0217 |
| 23 |
ENGRAFT FAILURE |
6 |
0.0209 |
| 24 |
FEMALE GENITAL TRACT FISTULA |
34 |
0.0199 |
| 25 |
PSEUDO-BARTTER SYNDROME |
2 |
0.0192 |
| 26 |
MESENTERIC LYMPHADENITIS |
1 |
0.0192 |
| 27 |
INFECTION PROTOZOAL |
1 |
0.0175 |
| 28 |
RETINOIC ACID SYNDROME |
3 |
0.0174 |
| 29 |
POST PROCEDURAL OEDEMA |
4 |
0.0172 |
| 30 |
CEREBRAL MICROINFARCTION |
1 |
0.0172 |
| 31 |
ENGRAFTMENT SYNDROME |
10 |
0.0169 |
| 32 |
AEROMONAS INFECTION |
3 |
0.0159 |
| 33 |
CAPILLARY PERMEABILITY INCREASED |
1 |
0.0154 |
| 34 |
HEPATIC AMOEBIASIS |
1 |
0.0149 |
| 35 |
MACULAR DEGENERATION |
176 |
0.0147 |
| 36 |
PTERYGIUM |
5 |
0.0145 |
| 37 |
BACTERIAL CULTURE POSITIVE |
1 |
0.0141 |
| 38 |
CYTOMEGALOVIRUS MUCOCUTANEOUS ULCER |
1 |
0.0139 |
| 39 |
NEUROMUSCULAR BLOCKADE |
3 |
0.0134 |
| 40 |
CEREBRAL VENTRICLE COLLAPSE |
1 |
0.0133 |
| 41 |
BACTERIAL TRANSLOCATION |
4 |
0.0126 |
| 42 |
PERIPHERAL VEIN THROMBOSIS |
3 |
0.0126 |
| 43 |
RADICULOPATHY |
33 |
0.0125 |
| 44 |
DYSBIOSIS |
10 |
0.0122 |
| 45 |
HYPOPHARYNGEAL CANCER |
1 |
0.0119 |
| 46 |
CYTOMEGALOVIRUS TEST POSITIVE |
21 |
0.0118 |
| 47 |
PROCTITIS |
33 |
0.0118 |
| 48 |
FOETAL HEART RATE INCREASED |
1 |
0.0114 |
| 49 |
HERPES SIMPLEX MENINGOENCEPHALITIS |
1 |
0.0112 |
| 50 |
CHRONIC SINUSITIS |
41 |
0.0109 |
| 51 |
HUMAN BOCAVIRUS INFECTION |
2 |
0.0106 |
| 52 |
CREATINE PHOSPHOKINASE DECREASED |
1 |
0.0105 |
| 53 |
FOETAL MOVEMENTS DECREASED |
1 |
0.0098 |
| 54 |
BAND NEUTROPHIL PERCENTAGE INCREASED |
1 |
0.0096 |
| 55 |
ABDOMINAL COMPARTMENT SYNDROME |
6 |
0.0094 |
| 56 |
STAPHYLOCOCCAL SCALDED SKIN SYNDROME |
2 |
0.0089 |
| 57 |
CONJUNCTIVAL EROSION |
1 |
0.0083 |
| 58 |
BRACHIOCEPHALIC VEIN THROMBOSIS |
1 |
0.0081 |
| 59 |
CHEST WALL MASS |
2 |
0.0077 |
| 60 |
MUCOUS MEMBRANE DISORDER |
10 |
0.0073 |
| 61 |
ENTEROCOLITIS BACTERIAL |
2 |
0.0072 |
| 62 |
TRAUMATIC HAEMOTHORAX |
2 |
0.0072 |
| 63 |
RESPIRATORY TRACT INFECTION |
187 |
0.0072 |
| 64 |
CSF CELL COUNT INCREASED |
1 |
0.0068 |
| 65 |
FIBRIN DEGRADATION PRODUCTS INCREASED |
2 |
0.0068 |
| 66 |
DIAPHRAGMATIC PARALYSIS |
4 |
0.0067 |
| 67 |
ASPERGILLUS TEST POSITIVE |
2 |
0.0065 |
| 68 |
BACILLUS INFECTION |
4 |
0.0063 |
| 69 |
CYTOMEGALOVIRUS ANTIBODY POSITIVE |
1 |
0.0063 |
| 70 |
CENTRAL NERVOUS SYSTEM NEOPLASM |
1 |
0.0062 |
| 71 |
GRAFT VERSUS HOST DISEASE IN LIVER |
4 |
0.0056 |
| 72 |
CRYPTOGENIC ORGANISING PNEUMONIA |
1 |
0.0054 |
| 73 |
ACCELERATED HYPERTENSION |
2 |
0.0053 |
| 74 |
CYSTITIS VIRAL |
2 |
0.0052 |
| 75 |
CHOROIDAL HAEMORRHAGE |
1 |
0.0052 |
| 76 |
EYE INFECTION FUNGAL |
2 |
0.0052 |
| 77 |
GENITAL TRACT INFLAMMATION |
1 |
0.0050 |
| 78 |
DEPENDENCE ON RESPIRATOR |
2 |
0.0050 |
| 79 |
SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA |
4 |
0.0049 |
| 80 |
BACTERIAL DIARRHOEA |
1 |
0.0047 |
| 81 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
13 |
0.0047 |
| 82 |
DISSEMINATED CYTOMEGALOVIRAL INFECTION |
1 |
0.0046 |
| 83 |
KLEBSIELLA TEST POSITIVE |
3 |
0.0046 |
| 84 |
ACINETOBACTER INFECTION |
5 |
0.0046 |
| 85 |
IRON BINDING CAPACITY TOTAL DECREASED |
1 |
0.0045 |
| 86 |
DRUG CLEARANCE INCREASED |
1 |
0.0045 |
| 87 |
ILIOTIBIAL BAND SYNDROME |
1 |
0.0044 |
| 88 |
BLOOD FIBRINOGEN DECREASED |
5 |
0.0044 |
| 89 |
FOETAL HEART RATE DECELERATION |
1 |
0.0043 |
| 90 |
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY |
1 |
0.0043 |
| 91 |
SJS-TEN OVERLAP |
3 |
0.0043 |
| 92 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
6 |
0.0042 |
| 93 |
EXTRAVASATION BLOOD |
1 |
0.0042 |
| 94 |
CHRONIC GRAFT VERSUS HOST DISEASE |
15 |
0.0042 |
| 95 |
ENCEPHALITIS HERPES |
2 |
0.0040 |
| 96 |
PNEUMOMEDIASTINUM |
7 |
0.0039 |
| 97 |
OEDEMA |
208 |
0.0038 |
| 98 |
BACTEROIDES INFECTION |
1 |
0.0038 |
| 99 |
HERPES ZOSTER REACTIVATION |
1 |
0.0038 |
| 100 |
HERPES ZOSTER DISSEMINATED |
3 |
0.0037 |
| 101 |
HYPERAMYLASAEMIA |
2 |
0.0037 |
| 102 |
ANTITHROMBIN III DECREASED |
1 |
0.0037 |
| 103 |
BLOOD CHOLINESTERASE DECREASED |
1 |
0.0036 |
| 104 |
SEPTIC EMBOLUS |
3 |
0.0036 |
| 105 |
PATHOGEN RESISTANCE |
32 |
0.0035 |
| 106 |
EYE INFECTION STAPHYLOCOCCAL |
1 |
0.0035 |
| 107 |
HYPERTENSIVE ENCEPHALOPATHY |
2 |
0.0034 |
| 108 |
KNEE DEFORMITY |
5 |
0.0034 |
| 109 |
CARDIAC FUNCTION TEST ABNORMAL |
1 |
0.0034 |
| 110 |
URINARY TRACT INFECTION PSEUDOMONAL |
2 |
0.0033 |
| 111 |
ELECTROCARDIOGRAM QT SHORTENED |
1 |
0.0033 |
| 112 |
VAGINAL DISCHARGE |
33 |
0.0033 |
| 113 |
HEPATIC ISCHAEMIA |
1 |
0.0032 |
| 114 |
PARAESTHESIA ORAL |
46 |
0.0032 |
| 115 |
GRAFT VERSUS HOST DISEASE IN SKIN |
7 |
0.0032 |
| 116 |
ASPERGILLOMA |
1 |
0.0031 |
| 117 |
HAEMATOLOGY TEST ABNORMAL |
1 |
0.0031 |
| 118 |
CELLULITE |
1 |
0.0031 |
| 119 |
WHEEZING |
181 |
0.0030 |
| 120 |
CAROTID ARTERY ANEURYSM |
1 |
0.0029 |
| 121 |
VIRAL HAEMORRHAGIC CYSTITIS |
2 |
0.0028 |
| 122 |
KLEBSIELLA INFECTION |
14 |
0.0028 |
| 123 |
ORAL CANDIDIASIS |
36 |
0.0027 |
| 124 |
CENTRAL LINE INFECTION |
1 |
0.0027 |
| 125 |
KLEBSIELLA SEPSIS |
3 |
0.0027 |
| 126 |
INSTILLATION SITE PRURITUS |
1 |
0.0027 |
| 127 |
HYDROURETER |
1 |
0.0026 |
| 128 |
COAGULATION TEST ABNORMAL |
2 |
0.0026 |
| 129 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
2 |
0.0026 |
| 130 |
ADMINISTRATION SITE REACTION |
1 |
0.0026 |
| 131 |
MICROANGIOPATHIC HAEMOLYTIC ANAEMIA |
2 |
0.0025 |
| 132 |
ANTIBIOTIC LEVEL ABOVE THERAPEUTIC |
1 |
0.0025 |
| 133 |
LYMPHOCYTIC LEUKAEMIA |
1 |
0.0025 |
| 134 |
OTITIS EXTERNA |
3 |
0.0025 |
| 135 |
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT |
2 |
0.0024 |
| 136 |
FUNGAL SEPSIS |
2 |
0.0024 |
| 137 |
ACUTE GRAFT VERSUS HOST DISEASE |
11 |
0.0024 |
| 138 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED |
1 |
0.0024 |
| 139 |
MUSCLE STRENGTH ABNORMAL |
1 |
0.0024 |
| 140 |
JOINT SURGERY |
1 |
0.0023 |
| 141 |
EYELID INFECTION |
1 |
0.0023 |
| 142 |
CARDIAC OUTPUT DECREASED |
2 |
0.0023 |
| 143 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
4 |
0.0023 |
| 144 |
PSEUDOMEMBRANOUS COLITIS |
5 |
0.0022 |
| 145 |
CORNEAL ABRASION |
3 |
0.0022 |
| 146 |
VASOSPASM |
2 |
0.0022 |
| 147 |
PNEUMONIA KLEBSIELLA |
4 |
0.0022 |
| 148 |
DYSPHASIA |
1 |
0.0021 |
| 149 |
GASTROINTESTINAL STOMA OUTPUT INCREASED |
1 |
0.0021 |
| 150 |
GRAFT VERSUS HOST DISEASE IN LUNG |
1 |
0.0021 |
| 151 |
BLOOD BICARBONATE INCREASED |
1 |
0.0021 |
| 152 |
BONE MARROW DEPRESSION |
2 |
0.0020 |
| 153 |
ARTERIOVENOUS FISTULA |
1 |
0.0020 |
| 154 |
HYPERSPLENISM |
1 |
0.0020 |
| 155 |
GENITAL ERYTHEMA |
1 |
0.0020 |
| 156 |
MUSCLE HAEMORRHAGE |
8 |
0.0020 |
| 157 |
DISSEMINATED INTRAVASCULAR COAGULATION |
28 |
0.0020 |
| 158 |
BLAST CELL COUNT INCREASED |
2 |
0.0019 |
| 159 |
GASTRIC ANTRAL VASCULAR ECTASIA |
1 |
0.0019 |
| 160 |
ANAL STENOSIS |
1 |
0.0019 |
| 161 |
INADEQUATE DIET |
1 |
0.0019 |
| 162 |
CORYNEBACTERIUM INFECTION |
1 |
0.0019 |
| 163 |
ASTHMA |
207 |
0.0018 |
| 164 |
MILK ALLERGY |
1 |
0.0018 |
| 165 |
CYTOMEGALOVIRUS VIRAEMIA |
8 |
0.0018 |
| 166 |
VANISHING BILE DUCT SYNDROME |
2 |
0.0018 |
| 167 |
RENAL TUBULAR DISORDER |
5 |
0.0018 |
| 168 |
APNOEIC ATTACK |
1 |
0.0018 |
| 169 |
PSEUDOMONAL SEPSIS |
3 |
0.0017 |
| 170 |
GRAFT COMPLICATION |
1 |
0.0017 |
| 171 |
RENAL TUBULAR INJURY |
2 |
0.0016 |
| 172 |
DRUG RESISTANCE |
42 |
0.0016 |
| 173 |
STAPHYLOCOCCAL SKIN INFECTION |
2 |
0.0016 |
| 174 |
MONOCYTOSIS |
1 |
0.0016 |
| 175 |
LEUKOENCEPHALOPATHY |
6 |
0.0016 |
| 176 |
VENOOCCLUSIVE DISEASE |
4 |
0.0016 |
| 177 |
NECROTISING COLITIS |
2 |
0.0016 |
| 178 |
PNEUMONIA CYTOMEGALOVIRAL |
3 |
0.0015 |
| 179 |
GASTROINTESTINAL MUCOSAL DISORDER |
1 |
0.0015 |
| 180 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
5 |
0.0015 |
| 181 |
SKIN HYPERPIGMENTATION |
13 |
0.0015 |
| 182 |
EMBOLIC CEREBRAL INFARCTION |
1 |
0.0015 |
| 183 |
HYPOPLASTIC LEFT HEART SYNDROME |
1 |
0.0015 |
| 184 |
EYELID PAIN |
3 |
0.0015 |
| 185 |
STENOTROPHOMONAS INFECTION |
2 |
0.0015 |
| 186 |
INFECTIOUS PERITONITIS |
1 |
0.0015 |
| 187 |
CYTOKINE STORM |
1 |
0.0015 |
| 188 |
WOUND COMPLICATION |
5 |
0.0015 |
| 189 |
NEUTROPENIC COLITIS |
3 |
0.0014 |
| 190 |
ENTEROCOCCAL INFECTION |
7 |
0.0014 |
| 191 |
PROCEDURAL PAIN |
40 |
0.0014 |
| 192 |
EPSTEIN-BARR VIRUS INFECTION |
9 |
0.0014 |
| 193 |
GLASSY EYES |
1 |
0.0014 |
| 194 |
MONOCYTE PERCENTAGE INCREASED |
1 |
0.0014 |
| 195 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
3 |
0.0014 |
| 196 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
1 |
0.0014 |
| 197 |
ANTIBODY TEST ABNORMAL |
1 |
0.0014 |
| 198 |
GASTRIC MUCOSAL LESION |
1 |
0.0014 |
| 199 |
BENIGN NEOPLASM OF THYROID GLAND |
1 |
0.0014 |
| 200 |
MYASTHENIA GRAVIS CRISIS |
2 |
0.0013 |
| 201 |
CHOLESTATIC LIVER INJURY |
3 |
0.0013 |
| 202 |
HISTIOCYTOSIS HAEMATOPHAGIC |
4 |
0.0013 |
| 203 |
ARTERIAL INJURY |
1 |
0.0013 |
| 204 |
HEART SOUNDS ABNORMAL |
1 |
0.0013 |
| 205 |
ARTERIAL RUPTURE |
1 |
0.0013 |
| 206 |
OSTEOMALACIA |
2 |
0.0013 |
| 207 |
ELECTROCARDIOGRAM T WAVE ABNORMAL |
2 |
0.0013 |
| 208 |
INFECTION PARASITIC |
1 |
0.0013 |
| 209 |
FREQUENT BOWEL MOVEMENTS |
34 |
0.0013 |
| 210 |
GRAFT VERSUS HOST DISEASE |
9 |
0.0013 |
| 211 |
LYMPHOCYTE STIMULATION TEST POSITIVE |
1 |
0.0012 |
| 212 |
METABOLIC ALKALOSIS |
2 |
0.0012 |
| 213 |
HAPTOGLOBIN DECREASED |
1 |
0.0012 |
| 214 |
THROMBOTIC MICROANGIOPATHY |
12 |
0.0012 |
| 215 |
LUNG OPERATION |
1 |
0.0012 |
| 216 |
BLOOD PH DECREASED |
2 |
0.0012 |
| 217 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
3 |
0.0012 |
| 218 |
BLOOD CHLORIDE INCREASED |
2 |
0.0012 |
| 219 |
RETINITIS |
2 |
0.0012 |
| 220 |
NECROTISING FASCIITIS |
4 |
0.0011 |
| 221 |
JUGULAR VEIN THROMBOSIS |
2 |
0.0011 |
| 222 |
CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION |
1 |
0.0011 |
| 223 |
DRUG DETOXIFICATION |
1 |
0.0011 |
| 224 |
HYPERLACTACIDAEMIA |
3 |
0.0011 |
| 225 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
5 |
0.0011 |
| 226 |
CHEST PAIN |
202 |
0.0011 |
| 227 |
LOBAR PNEUMONIA |
2 |
0.0011 |
| 228 |
C-REACTIVE PROTEIN |
1 |
0.0011 |
| 229 |
HEPATIC FUNCTION ABNORMAL |
40 |
0.0011 |
| 230 |
NEPHROPATHY TOXIC |
12 |
0.0011 |
| 231 |
PROTEIN TOTAL DECREASED |
4 |
0.0011 |
| 232 |
BRAIN STEM HAEMORRHAGE |
1 |
0.0011 |
| 233 |
DELAYED RECOVERY FROM ANAESTHESIA |
1 |
0.0011 |
| 234 |
HYPOPROTEINAEMIA |
2 |
0.0011 |
| 235 |
KLEBSIELLA BACTERAEMIA |
1 |
0.0011 |
| 236 |
BLOOD URINE |
1 |
0.0010 |
| 237 |
COARCTATION OF THE AORTA |
1 |
0.0010 |
| 238 |
ADENOVIRUS INFECTION |
3 |
0.0010 |
| 239 |
BRONCHOPULMONARY ASPERGILLOSIS |
8 |
0.0010 |
| 240 |
CYTOMEGALOVIRUS INFECTION |
17 |
0.0010 |
| 241 |
CONTINUOUS HAEMODIAFILTRATION |
1 |
0.0010 |
| 242 |
HAEMOPHILUS INFECTION |
1 |
0.0010 |
| 243 |
DUODENAL PERFORATION |
1 |
0.0010 |
| 244 |
VENOOCCLUSIVE LIVER DISEASE |
5 |
0.0010 |
| 245 |
GENE MUTATION |
2 |
0.0010 |
| 246 |
EMPYEMA |
2 |
0.0010 |
| 247 |
CYSTITIS HAEMORRHAGIC |
4 |
0.0010 |
| 248 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
5 |
0.0010 |
| 249 |
CORONAVIRUS TEST POSITIVE |
1 |
0.0010 |
| 250 |
CAROTID ARTERIOSCLEROSIS |
1 |
0.0010 |
| 251 |
CAPILLARY LEAK SYNDROME |
2 |
0.0010 |
| 252 |
MULTIPLE-DRUG RESISTANCE |
3 |
0.0010 |
| 253 |
VARICELLA ZOSTER VIRUS INFECTION |
2 |
0.0010 |
| 254 |
HEART TRANSPLANT REJECTION |
1 |
0.0010 |
| 255 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
27 |
0.0010 |
| 256 |
IRIDOCYCLITIS |
3 |
0.0009 |
| 257 |
BONE DEMINERALISATION |
1 |
0.0009 |
| 258 |
BLOOD SODIUM ABNORMAL |
1 |
0.0009 |
| 259 |
RADIATION PNEUMONITIS |
2 |
0.0009 |
| 260 |
PSEUDOMONAS INFECTION |
8 |
0.0009 |
| 261 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
2 |
0.0009 |
| 262 |
COLITIS |
35 |
0.0009 |
| 263 |
BACTERIAL SEPSIS |
3 |
0.0009 |
| 264 |
INSTILLATION SITE REACTION |
1 |
0.0009 |
| 265 |
NEUROTOXICITY |
16 |
0.0009 |
| 266 |
CLOSTRIDIUM TEST POSITIVE |
2 |
0.0009 |
| 267 |
HYPOALBUMINAEMIA |
7 |
0.0009 |
| 268 |
SUSPECTED OFF LABEL USE |
4 |
0.0009 |
| 269 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
2 |
0.0009 |
| 270 |
PNEUMONIA BACTERIAL |
8 |
0.0009 |
| 271 |
CARBON DIOXIDE DECREASED |
1 |
0.0009 |
| 272 |
LUMBAR RADICULOPATHY |
1 |
0.0009 |
| 273 |
BILIRUBIN CONJUGATED INCREASED |
2 |
0.0009 |
| 274 |
CONJUNCTIVAL HYPERAEMIA |
3 |
0.0008 |
| 275 |
EYELID SKIN DRYNESS |
1 |
0.0008 |
| 276 |
CLOSTRIDIUM COLITIS |
1 |
0.0008 |
| 277 |
FEBRILE CONVULSION |
1 |
0.0008 |
| 278 |
STAPHYLOCOCCAL SEPSIS |
4 |
0.0008 |
| 279 |
HYPERPARATHYROIDISM SECONDARY |
2 |
0.0008 |
| 280 |
SYSTEMIC CANDIDA |
2 |
0.0008 |
| 281 |
BETA HAEMOLYTIC STREPTOCOCCAL INFECTION |
1 |
0.0008 |
| 282 |
RECTAL HAEMORRHAGE |
34 |
0.0008 |
| 283 |
URINARY TRACT INFECTION BACTERIAL |
2 |
0.0008 |
| 284 |
GLUCOSE URINE PRESENT |
1 |
0.0008 |
| 285 |
PNEUMONIA |
254 |
0.0008 |
| 286 |
IATROGENIC INJURY |
1 |
0.0008 |
| 287 |
ACQUIRED GENE MUTATION |
1 |
0.0008 |
| 288 |
COLITIS ULCERATIVE |
34 |
0.0008 |
| 289 |
BLOOD ALBUMIN DECREASED |
6 |
0.0008 |
| 290 |
CLOSTRIDIUM DIFFICILE COLITIS |
8 |
0.0008 |
| 291 |
LYMPHOCYTE PERCENTAGE DECREASED |
1 |
0.0007 |
| 292 |
GLYCOSURIA |
1 |
0.0007 |
| 293 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
13 |
0.0007 |
| 294 |
CARBON DIOXIDE INCREASED |
1 |
0.0007 |
| 295 |
EFFUSION |
1 |
0.0007 |
| 296 |
TYPE IV HYPERSENSITIVITY REACTION |
2 |
0.0007 |
| 297 |
ABSCESS ORAL |
1 |
0.0007 |
| 298 |
INFUSION RELATED REACTION |
47 |
0.0007 |
| 299 |
HYPERPYREXIA |
3 |
0.0007 |
| 300 |
MENINGITIS BACTERIAL |
1 |
0.0007 |
| 301 |
INJECTION SITE HYPOAESTHESIA |
1 |
0.0007 |
| 302 |
BACTERIAL INFECTION |
13 |
0.0007 |
| 303 |
BRAIN HERNIATION |
2 |
0.0007 |
| 304 |
SEPTIC SHOCK |
29 |
0.0007 |
| 305 |
ADHESION |
1 |
0.0007 |
| 306 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
1 |
0.0007 |
| 307 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
36 |
0.0007 |
| 308 |
HAEMATOCHEZIA |
36 |
0.0007 |
| 309 |
DUODENITIS |
2 |
0.0007 |
| 310 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
2 |
0.0006 |
| 311 |
MEAN CELL VOLUME DECREASED |
1 |
0.0006 |
| 312 |
NEPHROGENIC ANAEMIA |
3 |
0.0006 |
| 313 |
COAGULATION TIME PROLONGED |
1 |
0.0006 |
| 314 |
EYELIDS PRURITUS |
2 |
0.0006 |
| 315 |
COUGH |
180 |
0.0006 |
| 316 |
ELECTROENCEPHALOGRAM ABNORMAL |
2 |
0.0006 |
| 317 |
INHIBITORY DRUG INTERACTION |
1 |
0.0006 |
| 318 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
10 |
0.0006 |
| 319 |
BLADDER PAIN |
2 |
0.0006 |
| 320 |
ENTERITIS |
4 |
0.0006 |
| 321 |
RASH VESICULAR |
3 |
0.0006 |
| 322 |
FEBRILE NEUTROPENIA |
41 |
0.0006 |
| 323 |
MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED |
1 |
0.0006 |
| 324 |
EMPHYSEMA |
6 |
0.0006 |
| 325 |
CLOSTRIDIAL INFECTION |
2 |
0.0006 |
| 326 |
BONE MARROW FAILURE |
12 |
0.0006 |
| 327 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
42 |
0.0006 |
| 328 |
MILIARIA |
1 |
0.0006 |
| 329 |
CERVICAL SPINAL STENOSIS |
1 |
0.0006 |
| 330 |
BLOOD CREATININE ABNORMAL |
2 |
0.0006 |
| 331 |
MALAISE |
253 |
0.0006 |
| 332 |
APLASTIC ANAEMIA |
3 |
0.0006 |
| 333 |
FANCONI SYNDROME ACQUIRED |
1 |
0.0006 |
| 334 |
SERUM FERRITIN INCREASED |
3 |
0.0006 |
| 335 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
2 |
0.0006 |
| 336 |
PNEUMOTHORAX |
9 |
0.0006 |
| 337 |
BLOOD BILIRUBIN INCREASED |
15 |
0.0006 |
| 338 |
MONOCYTE COUNT INCREASED |
2 |
0.0006 |
| 339 |
MEAN CELL HAEMOGLOBIN DECREASED |
1 |
0.0005 |
| 340 |
ESSENTIAL HYPERTENSION |
1 |
0.0005 |
| 341 |
ACUTE KIDNEY INJURY |
83 |
0.0005 |
| 342 |
CYSTIC FIBROSIS |
3 |
0.0005 |
| 343 |
GASTRIC ULCER HAEMORRHAGE |
3 |
0.0005 |
| 344 |
COAGULOPATHY |
9 |
0.0005 |
| 345 |
DEFORMITY |
5 |
0.0005 |
| 346 |
RESPIRATORY FAILURE |
39 |
0.0005 |
| 347 |
EYE INFECTION |
6 |
0.0005 |
| 348 |
HUMAN HERPESVIRUS 6 INFECTION |
1 |
0.0005 |
| 349 |
CATHETER SITE INFECTION |
2 |
0.0005 |
| 350 |
BLOOD BICARBONATE DECREASED |
1 |
0.0005 |
| 351 |
CARDIAC VALVE DISEASE |
3 |
0.0005 |
| 352 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
2 |
0.0005 |
| 353 |
HAEMOLYSIS |
4 |
0.0005 |
| 354 |
CYTOMEGALOVIRUS CHORIORETINITIS |
1 |
0.0005 |
| 355 |
PULMONARY HAEMORRHAGE |
4 |
0.0005 |
| 356 |
APLASIA |
1 |
0.0005 |
| 357 |
HYPERAEMIA |
1 |
0.0005 |
| 358 |
CANDIDIASIS |
2 |
0.0005 |
| 359 |
FOAMING AT MOUTH |
1 |
0.0005 |
| 360 |
MYASTHENIA GRAVIS |
4 |
0.0005 |
| 361 |
SEPSIS |
55 |
0.0005 |
| 362 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
22 |
0.0005 |
| 363 |
ENCEPHALOPATHY |
12 |
0.0005 |
| 364 |
CONJUNCTIVITIS |
9 |
0.0005 |
| 365 |
BODY TEMPERATURE FLUCTUATION |
1 |
0.0005 |
| 366 |
SWELLING OF EYELID |
3 |
0.0005 |
| 367 |
ALANINE AMINOTRANSFERASE ABNORMAL |
1 |
0.0005 |
| 368 |
VOMITING |
222 |
0.0005 |
| 369 |
FOETAL DISTRESS SYNDROME |
1 |
0.0005 |
| 370 |
LUNG NEOPLASM |
2 |
0.0005 |
| 371 |
MEDICAL DEVICE PAIN |
1 |
0.0005 |
| 372 |
HERPES SIMPLEX |
3 |
0.0005 |
| 373 |
SKIN LACERATION |
5 |
0.0005 |
| 374 |
PAIN |
282 |
0.0005 |
| 375 |
TREATMENT FAILURE |
38 |
0.0005 |
| 376 |
ASPERGILLUS INFECTION |
3 |
0.0005 |
| 377 |
CORNEAL DISORDER |
1 |
0.0005 |
| 378 |
LIMB MASS |
1 |
0.0005 |
| 379 |
LUNG INFILTRATION |
4 |
0.0005 |
| 380 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
2 |
0.0005 |
| 381 |
RENAL IMPAIRMENT |
38 |
0.0005 |
| 382 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
10 |
0.0005 |
| 383 |
FOOT DEFORMITY |
5 |
0.0005 |
| 384 |
LARGE INTESTINAL OBSTRUCTION |
1 |
0.0004 |
| 385 |
JOINT RANGE OF MOTION DECREASED |
6 |
0.0004 |
| 386 |
MENINGITIS ASEPTIC |
2 |
0.0004 |
| 387 |
PAPILLOEDEMA |
2 |
0.0004 |
| 388 |
NEUTROPHIL COUNT DECREASED |
18 |
0.0004 |
| 389 |
COMPUTERISED TOMOGRAM ABNORMAL |
1 |
0.0004 |
| 390 |
TACHYPNOEA |
6 |
0.0004 |
| 391 |
C-REACTIVE PROTEIN INCREASED |
16 |
0.0004 |
| 392 |
CYTOMEGALOVIRUS COLITIS |
1 |
0.0004 |
| 393 |
HYPOMAGNESAEMIA |
6 |
0.0004 |
| 394 |
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS |
1 |
0.0004 |
| 395 |
NEPHROPATHY |
4 |
0.0004 |
| 396 |
DYSPEPSIA |
42 |
0.0004 |
| 397 |
PLATELET COUNT DECREASED |
45 |
0.0004 |
| 398 |
ATAXIA |
5 |
0.0004 |
| 399 |
BLOOD UREA INCREASED |
7 |
0.0004 |
| 400 |
KIDNEY TRANSPLANT REJECTION |
2 |
0.0004 |
| 401 |
ALTERED STATE OF CONSCIOUSNESS |
9 |
0.0004 |
| 402 |
MOUTH HAEMORRHAGE |
3 |
0.0004 |
| 403 |
GLOMERULONEPHRITIS |
1 |
0.0004 |
| 404 |
DERMAL CYST |
1 |
0.0004 |
| 405 |
INFREQUENT BOWEL MOVEMENTS |
1 |
0.0004 |
| 406 |
HYPERAMMONAEMIA |
2 |
0.0004 |
| 407 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
3 |
0.0004 |
| 408 |
EOSINOPHILIA |
7 |
0.0004 |
| 409 |
EYELID IRRITATION |
1 |
0.0004 |
| 410 |
HYPOAESTHESIA ORAL |
6 |
0.0004 |
| 411 |
BRAIN ABSCESS |
1 |
0.0004 |
| 412 |
TOXIC EPIDERMAL NECROLYSIS |
6 |
0.0004 |
| 413 |
TOXIC ENCEPHALOPATHY |
2 |
0.0004 |
| 414 |
DERMATOMYOSITIS |
1 |
0.0004 |
| 415 |
ABDOMINAL INFECTION |
1 |
0.0004 |
| 416 |
CANCER PAIN |
1 |
0.0004 |
| 417 |
MUCORMYCOSIS |
1 |
0.0004 |
| 418 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
1 |
0.0004 |
| 419 |
LEARNING DISABILITY |
2 |
0.0004 |
| 420 |
BLOOD SODIUM INCREASED |
1 |
0.0004 |
| 421 |
ERYTHEMA OF EYELID |
2 |
0.0004 |
| 422 |
BLOOD PHOSPHORUS INCREASED |
1 |
0.0004 |
| 423 |
ACUTE RESPIRATORY FAILURE |
7 |
0.0004 |
| 424 |
DRUG LEVEL INCREASED |
6 |
0.0004 |
| 425 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
9 |
0.0004 |
| 426 |
EOSINOPHIL COUNT INCREASED |
3 |
0.0004 |
| 427 |
STREPTOCOCCAL INFECTION |
2 |
0.0004 |
| 428 |
ANAL HAEMORRHAGE |
1 |
0.0004 |
| 429 |
PULMONARY ALVEOLAR HAEMORRHAGE |
2 |
0.0004 |
| 430 |
IMMUNE THROMBOCYTOPENIC PURPURA |
1 |
0.0004 |
| 431 |
DYSPNOEA |
200 |
0.0004 |
| 432 |
HAEMATOCRIT DECREASED |
7 |
0.0004 |
| 433 |
ANURIA |
3 |
0.0003 |
| 434 |
HYPOKALAEMIA |
16 |
0.0003 |
| 435 |
STOMATITIS |
21 |
0.0003 |
| 436 |
EYELID OEDEMA |
4 |
0.0003 |
| 437 |
BLOOD PARATHYROID HORMONE INCREASED |
1 |
0.0003 |
| 438 |
TUMOUR LYSIS SYNDROME |
3 |
0.0003 |
| 439 |
GLUCOSE TOLERANCE IMPAIRED |
2 |
0.0003 |
| 440 |
RESPIRATORY RATE INCREASED |
3 |
0.0003 |
| 441 |
BACTERAEMIA |
4 |
0.0003 |
| 442 |
INFUSION SITE REACTION |
1 |
0.0003 |
| 443 |
METABOLIC ENCEPHALOPATHY |
1 |
0.0003 |
| 444 |
CHEST X-RAY ABNORMAL |
1 |
0.0003 |
| 445 |
BRAIN DEATH |
1 |
0.0003 |
| 446 |
CHOLANGITIS |
2 |
0.0003 |
| 447 |
PHARYNGITIS |
4 |
0.0003 |
| 448 |
ACUTE MYELOID LEUKAEMIA |
5 |
0.0003 |
| 449 |
EYE INFLAMMATION |
3 |
0.0003 |
| 450 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
3 |
0.0003 |
| 451 |
ALANINE AMINOTRANSFERASE INCREASED |
19 |
0.0003 |
| 452 |
LIVER ABSCESS |
1 |
0.0003 |
| 453 |
FACET JOINT SYNDROME |
1 |
0.0003 |
| 454 |
HYPOVENTILATION |
1 |
0.0003 |
| 455 |
LYMPHOCYTE COUNT INCREASED |
1 |
0.0003 |
| 456 |
RENAL TUBULAR NECROSIS |
3 |
0.0003 |
| 457 |
WHITE BLOOD CELL COUNT DECREASED |
33 |
0.0003 |
| 458 |
ANAEMIA |
58 |
0.0003 |
| 459 |
LISTLESS |
1 |
0.0003 |
| 460 |
PYREXIA |
105 |
0.0003 |
| 461 |
RENAL INJURY |
9 |
0.0003 |
| 462 |
CHRONIC KIDNEY DISEASE |
23 |
0.0003 |
| 463 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
5 |
0.0003 |
| 464 |
BRONCHIECTASIS |
2 |
0.0003 |
| 465 |
LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV |
1 |
0.0003 |
| 466 |
CANDIDA INFECTION |
5 |
0.0003 |
| 467 |
BRONCHOPNEUMONIA |
1 |
0.0003 |
| 468 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
1 |
0.0003 |
| 469 |
LEFT VENTRICULAR FAILURE |
1 |
0.0003 |
| 470 |
MULTI-ORGAN FAILURE |
5 |
0.0003 |
| 471 |
THERAPY NON-RESPONDER |
13 |
0.0003 |
| 472 |
BRONCHIOLITIS |
1 |
0.0003 |
| 473 |
PAPULE |
2 |
0.0003 |
| 474 |
LOGORRHOEA |
1 |
0.0003 |
| 475 |
LUNG TRANSPLANT |
1 |
0.0003 |
| 476 |
DRUG ERUPTION |
5 |
0.0003 |
| 477 |
HAEMORRHAGE SUBCUTANEOUS |
1 |
0.0003 |
| 478 |
FIBRIN D DIMER INCREASED |
1 |
0.0003 |
| 479 |
HAEMORRHAGIC DIATHESIS |
1 |
0.0003 |
| 480 |
PARALYSIS |
4 |
0.0003 |
| 481 |
BONE LESION |
1 |
0.0003 |
| 482 |
LEUKOCYTOSIS |
5 |
0.0003 |
| 483 |
DERMATITIS BULLOUS |
2 |
0.0003 |
| 484 |
BLOOD CREATININE INCREASED |
18 |
0.0003 |
| 485 |
END STAGE RENAL DISEASE |
5 |
0.0003 |
| 486 |
AMYLASE INCREASED |
1 |
0.0003 |
| 487 |
CARDIAC DYSFUNCTION |
1 |
0.0003 |
| 488 |
INTERSTITIAL LUNG DISEASE |
13 |
0.0003 |
| 489 |
IMMUNODEFICIENCY |
4 |
0.0003 |
| 490 |
SKIN INFECTION |
3 |
0.0003 |
| 491 |
OCULAR DISCOMFORT |
3 |
0.0003 |
| 492 |
HYDRONEPHROSIS |
2 |
0.0003 |
| 493 |
HYPOCALCAEMIA |
5 |
0.0003 |
| 494 |
ECONOMIC PROBLEM |
4 |
0.0003 |
| 495 |
RHABDOMYOLYSIS |
11 |
0.0003 |
| 496 |
ASPARTATE AMINOTRANSFERASE INCREASED |
14 |
0.0003 |
| 497 |
FACE INJURY |
1 |
0.0003 |
| 498 |
ACIDOSIS |
2 |
0.0003 |
| 499 |
SHOCK |
6 |
0.0003 |
| 500 |
LEUKOPENIA |
13 |
0.0003 |
| 501 |
PERICARDIAL EFFUSION |
6 |
0.0003 |
| 502 |
RESPIRATORY ARREST |
7 |
0.0003 |
| 503 |
DRUG INEFFECTIVE |
333 |
0.0003 |
| 504 |
FURUNCLE |
2 |
0.0003 |
| 505 |
CEREBRAL ATROPHY |
1 |
0.0003 |
| 506 |
CREATININE RENAL CLEARANCE DECREASED |
1 |
0.0002 |
| 507 |
TRANSPLANT REJECTION |
2 |
0.0002 |
| 508 |
SPINAL FRACTURE |
5 |
0.0002 |
| 509 |
BLEPHARITIS |
1 |
0.0002 |
| 510 |
HYPERGLYCAEMIA |
9 |
0.0002 |
| 511 |
RHEUMATOID ARTHRITIS |
28 |
0.0002 |
| 512 |
DECUBITUS ULCER |
2 |
0.0002 |
| 513 |
RED BLOOD CELL COUNT DECREASED |
7 |
0.0002 |
| 514 |
ABNORMAL FAECES |
2 |
0.0002 |
| 515 |
CARDIOMEGALY |
3 |
0.0002 |
| 516 |
ESCHERICHIA INFECTION |
2 |
0.0002 |
| 517 |
AORTIC DISSECTION |
1 |
0.0002 |
| 518 |
GASTROINTESTINAL PERFORATION |
1 |
0.0002 |
| 519 |
CARDIO-RESPIRATORY ARREST |
10 |
0.0002 |
| 520 |
ABSCESS LIMB |
1 |
0.0002 |
| 521 |
CARDIAC FAILURE CHRONIC |
1 |
0.0002 |
| 522 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
6 |
0.0002 |
| 523 |
ANAPHYLACTIC SHOCK |
6 |
0.0002 |
| 524 |
HORDEOLUM |
1 |
0.0002 |
| 525 |
URINE OUTPUT DECREASED |
2 |
0.0002 |
| 526 |
SPINAL OSTEOARTHRITIS |
2 |
0.0002 |
| 527 |
HAEMORRHAGIC ANAEMIA |
1 |
0.0002 |
| 528 |
GINGIVAL SWELLING |
1 |
0.0002 |
| 529 |
BLOOD PRESSURE DECREASED |
15 |
0.0002 |
| 530 |
LIVER DISORDER |
10 |
0.0002 |
| 531 |
CARDIOTOXICITY |
2 |
0.0002 |
| 532 |
ILEUS PARALYTIC |
1 |
0.0002 |
| 533 |
GASTROINTESTINAL INFECTION |
2 |
0.0002 |
| 534 |
DRUG-INDUCED LIVER INJURY |
7 |
0.0002 |
| 535 |
PANCREATITIS ACUTE |
5 |
0.0002 |
| 536 |
MYELOSUPPRESSION |
8 |
0.0002 |
| 537 |
OPTIC NEURITIS |
2 |
0.0002 |
| 538 |
DRUG LEVEL ABOVE THERAPEUTIC |
1 |
0.0002 |
| 539 |
TUBULOINTERSTITIAL NEPHRITIS |
4 |
0.0002 |
| 540 |
STAPHYLOCOCCAL INFECTION |
7 |
0.0002 |
| 541 |
LYMPHOPENIA |
3 |
0.0002 |
| 542 |
LEUKAEMIA |
2 |
0.0002 |
| 543 |
RENAL FAILURE |
28 |
0.0002 |
| 544 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
1 |
0.0002 |
| 545 |
CARDIAC TAMPONADE |
1 |
0.0002 |
| 546 |
SINUS BRADYCARDIA |
2 |
0.0002 |
| 547 |
THROMBOCYTOPENIA |
23 |
0.0002 |
| 548 |
ERYTHEMA |
42 |
0.0002 |
| 549 |
HEPARIN-INDUCED THROMBOCYTOPENIA |
1 |
0.0002 |
| 550 |
BREATH SOUNDS ABNORMAL |
1 |
0.0002 |
| 551 |
MUCOUS STOOLS |
1 |
0.0002 |
| 552 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
1 |
0.0002 |
| 553 |
HYPERNATRAEMIA |
1 |
0.0002 |
| 554 |
FULL BLOOD COUNT DECREASED |
4 |
0.0002 |
| 555 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
0.0002 |
| 556 |
DRUG LEVEL DECREASED |
2 |
0.0002 |
| 557 |
SUBARACHNOID HAEMORRHAGE |
2 |
0.0002 |
| 558 |
FEMORAL NECK FRACTURE |
1 |
0.0002 |
| 559 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
2 |
0.0002 |
| 560 |
CEREBRAL ISCHAEMIA |
1 |
0.0002 |
| 561 |
BENIGN PROSTATIC HYPERPLASIA |
1 |
0.0002 |
| 562 |
ABDOMINAL PAIN |
45 |
0.0002 |
| 563 |
PERITONITIS |
4 |
0.0002 |
| 564 |
RASH GENERALISED |
5 |
0.0002 |
| 565 |
HYPERBILIRUBINAEMIA |
2 |
0.0002 |
| 566 |
HERPES ZOSTER |
11 |
0.0002 |
| 567 |
PREMATURE DELIVERY |
3 |
0.0002 |
| 568 |
EAR INFECTION |
5 |
0.0002 |
| 569 |
GASTROINTESTINAL MOTILITY DISORDER |
1 |
0.0002 |
| 570 |
FOOD POISONING |
1 |
0.0002 |
| 571 |
ANAL ABSCESS |
1 |
0.0002 |
| 572 |
GINGIVITIS |
1 |
0.0002 |
| 573 |
DECREASED ACTIVITY |
2 |
0.0002 |
| 574 |
CHEILITIS |
1 |
0.0002 |
| 575 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
1 |
0.0002 |
| 576 |
CONSTIPATION |
40 |
0.0002 |
| 577 |
WEIGHT DECREASED |
51 |
0.0002 |
| 578 |
JAW DISORDER |
1 |
0.0002 |
| 579 |
JOINT SWELLING |
22 |
0.0002 |
| 580 |
TRANSAMINASES INCREASED |
4 |
0.0002 |
| 581 |
MALNUTRITION |
2 |
0.0002 |
| 582 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
1 |
0.0002 |
| 583 |
OXYGEN SATURATION DECREASED |
10 |
0.0002 |
| 584 |
EYE PAIN |
10 |
0.0002 |
| 585 |
HYPERVENTILATION |
1 |
0.0002 |
| 586 |
VASCULITIS |
2 |
0.0002 |
| 587 |
HYPOVOLAEMIA |
1 |
0.0002 |
| 588 |
HYPERTRIGLYCERIDAEMIA |
1 |
0.0002 |
| 589 |
BRADYKINESIA |
1 |
0.0002 |
| 590 |
COVID-19 PNEUMONIA |
2 |
0.0002 |
| 591 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
1 |
0.0002 |
| 592 |
OFF LABEL USE |
146 |
0.0002 |
| 593 |
PLEURAL EFFUSION |
10 |
0.0002 |
| 594 |
NO THERAPEUTIC RESPONSE |
2 |
0.0002 |
| 595 |
CEREBRAL INFARCTION |
4 |
0.0002 |
| 596 |
LIVER INJURY |
4 |
0.0002 |
| 597 |
GENERALISED OEDEMA |
2 |
0.0002 |
| 598 |
HEPATIC ENZYME INCREASED |
11 |
0.0002 |
| 599 |
ILEUS |
2 |
0.0002 |
| 600 |
SECRETION DISCHARGE |
2 |
0.0002 |
| 601 |
HEPATIC CIRRHOSIS |
3 |
0.0002 |
| 602 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 603 |
PROTEINURIA |
3 |
0.0002 |
| 604 |
METABOLIC ACIDOSIS |
5 |
0.0002 |
| 605 |
C-REACTIVE PROTEIN ABNORMAL |
1 |
0.0002 |
| 606 |
PLATELET COUNT INCREASED |
2 |
0.0002 |
| 607 |
ANHEDONIA |
4 |
0.0002 |
| 608 |
PULMONARY CONGESTION |
2 |
0.0002 |
| 609 |
CARDIAC FAILURE ACUTE |
1 |
0.0001 |
| 610 |
EYE HAEMORRHAGE |
2 |
0.0001 |
| 611 |
URINARY RETENTION |
5 |
0.0001 |
| 612 |
MENINGITIS |
1 |
0.0001 |
| 613 |
BREAST MASS |
1 |
0.0001 |
| 614 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 615 |
ECCHYMOSIS |
1 |
0.0001 |
| 616 |
MENTAL STATUS CHANGES |
4 |
0.0001 |
| 617 |
LARGE INTESTINE PERFORATION |
1 |
0.0001 |
| 618 |
HYPERTRANSAMINASAEMIA |
1 |
0.0001 |
| 619 |
FORMICATION |
1 |
0.0001 |
| 620 |
GASTROINTESTINAL HAEMORRHAGE |
12 |
0.0001 |
| 621 |
EXTRASYSTOLES |
1 |
0.0001 |
| 622 |
DERMATITIS |
3 |
0.0001 |
| 623 |
BLOOD TEST ABNORMAL |
2 |
0.0001 |
| 624 |
HYPOXIA |
5 |
0.0001 |
| 625 |
DUODENAL ULCER |
1 |
0.0001 |
| 626 |
RENAL FAILURE ACUTE |
6 |
0.0001 |
| 627 |
PULMONARY ARTERIAL HYPERTENSION |
2 |
0.0001 |
| 628 |
CARDIAC FAILURE |
11 |
0.0001 |
| 629 |
MAJOR DEPRESSION |
1 |
0.0001 |
| 630 |
MELAENA |
3 |
0.0001 |
| 631 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0001 |
| 632 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 633 |
ARTHROPOD BITE |
1 |
0.0001 |
| 634 |
RASH MACULO-PAPULAR |
3 |
0.0001 |
| 635 |
CONDITION AGGRAVATED |
41 |
0.0001 |
| 636 |
HEPATOTOXICITY |
3 |
0.0001 |
| 637 |
DUODENAL ULCER PERFORATION |
1 |
0.0001 |
| 638 |
RESPIRATORY DISORDER |
4 |
0.0001 |
| 639 |
CARDIAC ARREST |
11 |
0.0001 |
| 640 |
BLOOD POTASSIUM DECREASED |
4 |
0.0001 |
| 641 |
LACRIMATION INCREASED |
4 |
0.0001 |
| 642 |
NEUTROPENIA |
18 |
0.0001 |
| 643 |
HAEMODYNAMIC INSTABILITY |
1 |
0.0001 |
| 644 |
HYPERTHERMIA |
1 |
0.0001 |
| 645 |
DRUG EFFECT DECREASED |
7 |
0.0001 |
| 646 |
DEVICE RELATED INFECTION |
2 |
0.0001 |
| 647 |
DIFFUSE LARGE B-CELL LYMPHOMA |
1 |
0.0001 |
| 648 |
LOW DENSITY LIPOPROTEIN INCREASED |
1 |
0.0001 |
| 649 |
APHTHOUS ULCER |
1 |
0.0001 |
| 650 |
LUNG INFECTION |
2 |
0.0001 |
| 651 |
EJECTION FRACTION DECREASED |
2 |
0.0001 |
| 652 |
APNOEA |
1 |
0.0001 |
| 653 |
NERVOUS SYSTEM DISORDER |
4 |
0.0001 |
| 654 |
HAEMORRHAGIC STROKE |
1 |
0.0001 |
| 655 |
GASTROINTESTINAL INFLAMMATION |
1 |
0.0001 |
| 656 |
MULTIPLE ALLERGIES |
1 |
0.0001 |
| 657 |
OCULAR HYPERAEMIA |
6 |
0.0001 |
| 658 |
LOW BIRTH WEIGHT BABY |
1 |
0.0001 |
| 659 |
GINGIVAL PAIN |
1 |
0.0001 |
| 660 |
PANCYTOPENIA |
7 |
0.0001 |
| 661 |
EYE DISORDER |
4 |
0.0001 |
| 662 |
EYE IRRITATION |
7 |
0.0001 |
| 663 |
DRY EYE |
6 |
0.0001 |
| 664 |
ATRIAL SEPTAL DEFECT |
1 |
0.0001 |
| 665 |
EYE PRURITUS |
4 |
0.0001 |
| 666 |
CATARACT |
7 |
0.0001 |
| 667 |
CIRCULATORY COLLAPSE |
2 |
0.0001 |
| 668 |
HAEMOGLOBIN DECREASED |
12 |
0.0001 |
| 669 |
DELIRIUM |
4 |
0.0001 |
| 670 |
NEOPLASM PROGRESSION |
4 |
0.0001 |
| 671 |
MUCOSAL INFLAMMATION |
3 |
0.0001 |
| 672 |
LYMPHOCYTE COUNT DECREASED |
2 |
0.0001 |
| 673 |
PULMONARY OEDEMA |
5 |
0.0001 |
| 674 |
HAEMOLYTIC ANAEMIA |
1 |
0.0001 |
| 675 |
JAUNDICE |
3 |
0.0001 |
| 676 |
DEVELOPMENTAL DELAY |
1 |
0.0001 |
| 677 |
GASTROENTERITIS VIRAL |
2 |
0.0001 |
| 678 |
PNEUMONITIS |
3 |
0.0001 |
| 679 |
LIP DRY |
1 |
0.0001 |
| 680 |
BRAIN NEOPLASM |
1 |
0.0001 |
| 681 |
INCREASED TENDENCY TO BRUISE |
1 |
0.0001 |
| 682 |
EYE SWELLING |
4 |
0.0001 |
| 683 |
NAUSEA |
85 |
0.0001 |
| 684 |
RENAL DISORDER |
5 |
0.0001 |
| 685 |
ERYTHEMA MULTIFORME |
1 |
0.0001 |
| 686 |
DYSARTHRIA |
4 |
0.0001 |
| 687 |
ARTERIOSCLEROSIS |
1 |
0.0001 |
| 688 |
PRODUCT DOSE OMISSION IN ERROR |
3 |
0.0001 |
| 689 |
ARRHYTHMIA |
5 |
0.0001 |
| 690 |
SLEEP APNOEA SYNDROME |
2 |
0.0001 |
| 691 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
3 |
0.0001 |
| 692 |
HYPERTENSION |
22 |
0.0001 |
| 693 |
INFECTION |
15 |
0.0001 |
| 694 |
ATELECTASIS |
1 |
0.0001 |
| 695 |
PRESCRIBED OVERDOSE |
2 |
0.0001 |
| 696 |
HAEMORRHOIDS |
2 |
0.0001 |
| 697 |
ORAL HERPES |
2 |
0.0001 |
| 698 |
ASCITES |
3 |
0.0001 |
| 699 |
ACUTE MYOCARDIAL INFARCTION |
3 |
0.0001 |
| 700 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
4 |
0.0001 |
| 701 |
HYPOTONIA |
1 |
0.0001 |
| 702 |
CYTOKINE RELEASE SYNDROME |
2 |
0.0001 |
| 703 |
HEPATIC FAILURE |
3 |
0.0001 |
| 704 |
EUPHORIC MOOD |
1 |
0.0001 |
| 705 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 706 |
EAR DISCOMFORT |
1 |
0.0001 |
| 707 |
HELICOBACTER INFECTION |
1 |
0.0001 |
| 708 |
EYE DISCHARGE |
1 |
0.0001 |
| 709 |
FOLLICULITIS |
1 |
0.0001 |
| 710 |
SKIN EXFOLIATION |
8 |
0.0001 |
| 711 |
JOINT DISLOCATION |
1 |
0.0001 |
| 712 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 713 |
DIARRHOEA |
61 |
0.0001 |
| 714 |
PRODUCT USE IN UNAPPROVED INDICATION |
23 |
0.0001 |
| 715 |
IMPAIRED HEALING |
3 |
0.0001 |
| 716 |
ASPIRATION |
1 |
0.0001 |
| 717 |
BLOOD GLUCOSE FLUCTUATION |
1 |
0.0001 |
| 718 |
COVID-19 |
16 |
0.0001 |
| 719 |
HEART RATE INCREASED |
9 |
0.0001 |
| 720 |
DENTAL CARIES |
1 |
0.0001 |
| 721 |
FUNGAL INFECTION |
3 |
0.0001 |
| 722 |
STEVENS-JOHNSON SYNDROME |
2 |
0.0001 |
| 723 |
MEDICATION ERROR |
5 |
0.0001 |
| 724 |
GLOSSODYNIA |
2 |
0.0001 |
| 725 |
BLISTER |
5 |
0.0001 |
| 726 |
FISTULA |
1 |
0.0001 |
| 727 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 728 |
HYPONATRAEMIA |
5 |
0.0001 |
| 729 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 730 |
HAEMATURIA |
3 |
0.0001 |
| 731 |
GASTRIC DISORDER |
3 |
0.0001 |
| 732 |
NEPHROLITHIASIS |
4 |
0.0001 |
| 733 |
UPPER RESPIRATORY TRACT INFECTION |
4 |
0.0001 |
| 734 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 735 |
CAESAREAN SECTION |
1 |
0.0001 |
| 736 |
HEART RATE DECREASED |
3 |
0.0001 |
| 737 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 738 |
CHOLECYSTITIS |
1 |
0.0001 |
| 739 |
CEREBRAL HAEMORRHAGE |
3 |
0.0001 |
| 740 |
ACCIDENT |
1 |
0.0001 |
| 741 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 742 |
RASH ERYTHEMATOUS |
4 |
0.0001 |
| 743 |
ELECTROCARDIOGRAM QT PROLONGED |
3 |
0.0001 |
| 744 |
BURSITIS |
1 |
0.0001 |
| 745 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 746 |
FIBROMYALGIA |
2 |
0.0001 |
| 747 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 748 |
EPISTAXIS |
6 |
0.0001 |
| 749 |
HYPOTENSION |
16 |
0.0001 |
| 750 |
HEADACHE |
50 |
0.0001 |
| 751 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 752 |
BRAIN OEDEMA |
1 |
0.0001 |
| 753 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 754 |
INTRAOCULAR PRESSURE INCREASED |
1 |
0.0001 |
| 755 |
WHITE BLOOD CELL COUNT INCREASED |
3 |
0.0001 |
| 756 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 757 |
ANOREXIA |
1 |
0.0001 |
| 758 |
UNRESPONSIVE TO STIMULI |
2 |
0.0001 |
| 759 |
PLASMA CELL MYELOMA |
3 |
0.0001 |
| 760 |
DEAFNESS |
2 |
0.0001 |
| 761 |
ECZEMA |
4 |
0.0001 |
| 762 |
HAND DEFORMITY |
1 |
0.0001 |
| 763 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 764 |
ADVERSE REACTION |
1 |
0.0001 |
| 765 |
DEHYDRATION |
10 |
0.0001 |
| 766 |
CARDIAC FAILURE CONGESTIVE |
6 |
0.0001 |
| 767 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 768 |
AKATHISIA |
1 |
0.0001 |
| 769 |
ACUTE HEPATIC FAILURE |
1 |
0.0001 |
| 770 |
OSTEOPOROSIS |
3 |
0.0001 |
| 771 |
APPLICATION SITE RASH |
1 |
0.0001 |
| 772 |
RESPIRATORY DISTRESS |
2 |
0.0001 |
| 773 |
ROAD TRAFFIC ACCIDENT |
3 |
0.0001 |
| 774 |
DEMENTIA |
2 |
0.0001 |
| 775 |
CARPAL TUNNEL SYNDROME |
1 |
0.0001 |
| 776 |
RASH |
31 |
0.0001 |
| 777 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 778 |
HEPATOCELLULAR INJURY |
1 |
0.0001 |
| 779 |
INTENTIONAL DOSE OMISSION |
2 |
0.0001 |
| 780 |
CONVULSION |
4 |
0.0001 |
| 781 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 782 |
DRUG INTERACTION |
11 |
0.0001 |
| 783 |
MENTAL DISORDER |
3 |
0.0001 |
| 784 |
FLUID OVERLOAD |
1 |
0.0001 |
| 785 |
GASTROENTERITIS |
1 |
0.0001 |
| 786 |
LABORATORY TEST ABNORMAL |
2 |
0.0001 |
| 787 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 788 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 789 |
BONE LOSS |
1 |
0.0001 |
| 790 |
PREMATURE BABY |
2 |
0.0001 |
| 791 |
INSURANCE ISSUE |
1 |
0.0001 |
| 792 |
SKIN DISCOLOURATION |
3 |
0.0001 |
| 793 |
SWELLING |
6 |
0.0001 |
| 794 |
BONE DENSITY DECREASED |
2 |
0.0001 |
| 795 |
ABSCESS |
1 |
0.0001 |
| 796 |
MOVEMENT DISORDER |
2 |
0.0001 |
| 797 |
DRUG INTOLERANCE |
6 |
0.0001 |
| 798 |
HYPOGLYCAEMIA |
3 |
0.0001 |
| 799 |
LACTIC ACIDOSIS |
2 |
0.0001 |
| 800 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 801 |
PRODUCT DOSE OMISSION |
4 |
0.0001 |
| 802 |
LIP SWELLING |
2 |
0.0001 |
| 803 |
CELLULITIS |
3 |
0.0001 |
| 804 |
TYPE 2 DIABETES MELLITUS |
2 |
0.0001 |
| 805 |
TOXICITY TO VARIOUS AGENTS |
10 |
0.0001 |
| 806 |
FACE OEDEMA |
1 |
0.0001 |
| 807 |
HYPERSENSITIVITY |
11 |
0.0001 |
| 808 |
DISEASE PROGRESSION |
7 |
0.0001 |
| 809 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 810 |
VISION BLURRED |
8 |
0.0001 |
| 811 |
INFLAMMATION |
3 |
0.0001 |
| 812 |
HAEMORRHAGE |
6 |
0.0001 |
| 813 |
PARAESTHESIA |
9 |
0.0001 |
| 814 |
RASH MACULAR |
2 |
0.0001 |
| 815 |
INTENTIONAL PRODUCT USE ISSUE |
5 |
0.0001 |
| 816 |
HYPERKALAEMIA |
2 |
0.0001 |
| 817 |
DERMATITIS ATOPIC |
3 |
0.0001 |
| 818 |
PANCREATITIS |
3 |
0.0001 |
| 819 |
SLEEP DISORDER |
4 |
0.0001 |
| 820 |
BRADYCARDIA |
3 |
0.0001 |
| 821 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
2 |
0.0001 |
| 822 |
BACK PAIN |
13 |
0.0001 |
| 823 |
GASTROINTESTINAL DISORDER |
5 |
0.0001 |
| 824 |
ADVERSE DRUG REACTION |
5 |
0.0001 |
| 825 |
RESTLESSNESS |
2 |
0.0001 |
| 826 |
PRURITUS |
21 |
0.0001 |
| 827 |
ANAPHYLACTIC REACTION |
3 |
0.0001 |
| 828 |
AGRANULOCYTOSIS |
1 |
0.0001 |
| 829 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 830 |
ABDOMINAL PAIN UPPER |
11 |
0.0001 |
| 831 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 832 |
GASTRIC ULCER |
1 |
0.0001 |
| 833 |
NEUROPATHY PERIPHERAL |
5 |
0.0001 |
| 834 |
FEELING JITTERY |
1 |
0.0001 |
| 835 |
CHOLESTASIS |
1 |
0.0001 |
| 836 |
GLAUCOMA |
1 |
0.0001 |
| 837 |
ERUCTATION |
1 |
0.0001 |
| 838 |
EAR PAIN |
1 |
0.0001 |
| 839 |
ATRIAL FIBRILLATION |
5 |
0.0001 |
| 840 |
NASAL CONGESTION |
3 |
0.0001 |
| 841 |
PRODUCT DOSE OMISSION ISSUE |
15 |
0.0001 |
| 842 |
KIDNEY INFECTION |
1 |
0.0001 |
| 843 |
DISORIENTATION |
2 |
0.0001 |
| 844 |
PSORIATIC ARTHROPATHY |
2 |
0.0000 |
| 845 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 846 |
INJECTION SITE WARMTH |
1 |
0.0000 |
| 847 |
VISUAL IMPAIRMENT |
6 |
0.0000 |
| 848 |
ABDOMINAL DISTENSION |
5 |
0.0000 |
| 849 |
URTICARIA |
8 |
0.0000 |
| 850 |
MOUTH ULCERATION |
1 |
0.0000 |
| 851 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 852 |
EATING DISORDER |
1 |
0.0000 |
| 853 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 854 |
HYPOACUSIS |
2 |
0.0000 |
| 855 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 856 |
ALOPECIA |
9 |
0.0000 |
| 857 |
TACHYCARDIA |
4 |
0.0000 |
| 858 |
INFLUENZA |
5 |
0.0000 |
| 859 |
LOWER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 860 |
TINNITUS |
2 |
0.0000 |
| 861 |
SEIZURE |
5 |
0.0000 |
| 862 |
DECREASED APPETITE |
10 |
0.0000 |
| 863 |
BURNING SENSATION |
3 |
0.0000 |
| 864 |
CHILLS |
5 |
0.0000 |
| 865 |
TREMOR |
7 |
0.0000 |
| 866 |
DYSPHAGIA |
4 |
0.0000 |
| 867 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 868 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 869 |
URINARY TRACT INFECTION |
7 |
0.0000 |
| 870 |
OEDEMA PERIPHERAL |
5 |
0.0000 |
| 871 |
LUNG DISORDER |
2 |
0.0000 |
| 872 |
BRONCHITIS |
3 |
0.0000 |
| 873 |
DYSGEUSIA |
3 |
0.0000 |
| 874 |
AGEUSIA |
1 |
0.0000 |
| 875 |
HYPOAESTHESIA |
6 |
0.0000 |
| 876 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 877 |
DEPRESSION |
9 |
0.0000 |
| 878 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 879 |
HEPATITIS |
1 |
0.0000 |
| 880 |
SINUSITIS |
4 |
0.0000 |
| 881 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
2 |
0.0000 |
| 882 |
JOINT STIFFNESS |
1 |
0.0000 |
| 883 |
GASTRITIS |
1 |
0.0000 |
| 884 |
INSOMNIA |
10 |
0.0000 |
| 885 |
PAIN IN EXTREMITY |
11 |
0.0000 |
| 886 |
THROMBOSIS |
3 |
0.0000 |
| 887 |
GASTROOESOPHAGEAL REFLUX DISEASE |
3 |
0.0000 |
| 888 |
DEATH |
32 |
0.0000 |
| 889 |
DRY MOUTH |
3 |
0.0000 |
| 890 |
FOETAL EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 891 |
MOOD ALTERED |
1 |
0.0000 |
| 892 |
GAIT DISTURBANCE |
7 |
0.0000 |
| 893 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 894 |
DIVERTICULITIS |
1 |
0.0000 |
| 895 |
FLATULENCE |
2 |
0.0000 |
| 896 |
MUSCULAR WEAKNESS |
4 |
0.0000 |
| 897 |
ANXIETY |
10 |
0.0000 |
| 898 |
BALANCE DISORDER |
3 |
0.0000 |
| 899 |
GENERAL PHYSICAL HEALTH DETERIORATION |
4 |
0.0000 |
| 900 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 901 |
BONE PAIN |
2 |
0.0000 |
| 902 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 903 |
MATERNAL EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 904 |
EMOTIONAL DISTRESS |
4 |
0.0000 |
| 905 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 906 |
ILL-DEFINED DISORDER |
2 |
0.0000 |
| 907 |
VERTIGO |
2 |
0.0000 |
| 908 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 909 |
HEAD INJURY |
1 |
0.0000 |
| 910 |
PULMONARY EMBOLISM |
3 |
0.0000 |
| 911 |
CYSTITIS |
1 |
0.0000 |
| 912 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 913 |
WEIGHT INCREASED |
7 |
0.0000 |
| 914 |
CONTUSION |
3 |
0.0000 |
| 915 |
DEEP VEIN THROMBOSIS |
2 |
0.0000 |
| 916 |
SWELLING FACE |
2 |
0.0000 |
| 917 |
PSORIASIS |
4 |
0.0000 |
| 918 |
CHOLELITHIASIS |
1 |
0.0000 |
| 919 |
FALL |
10 |
0.0000 |
| 920 |
SYNCOPE |
3 |
0.0000 |
| 921 |
DRY SKIN |
4 |
0.0000 |
| 922 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 923 |
FATIGUE |
23 |
0.0000 |
| 924 |
DRUG EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 925 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 926 |
MALIGNANT NEOPLASM PROGRESSION |
3 |
0.0000 |
| 927 |
ASTHENIA |
11 |
0.0000 |
| 928 |
MEMORY IMPAIRMENT |
4 |
0.0000 |
| 929 |
INJURY |
2 |
0.0000 |
| 930 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 931 |
SKIN BURNING SENSATION |
2 |
0.0000 |
| 932 |
CRYING |
1 |
0.0000 |
| 933 |
DYSURIA |
1 |
0.0000 |
| 934 |
INJECTION SITE MASS |
1 |
0.0000 |
| 935 |
PRODUCT USE ISSUE |
5 |
0.0000 |
| 936 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 937 |
HALLUCINATION |
2 |
0.0000 |
| 938 |
HOT FLUSH |
2 |
0.0000 |
| 939 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 940 |
DIZZINESS |
13 |
0.0000 |
| 941 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 942 |
SOMNOLENCE |
5 |
0.0000 |
| 943 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
5 |
0.0000 |
| 944 |
DYSKINESIA |
1 |
0.0000 |
| 945 |
BLINDNESS |
1 |
0.0000 |
| 946 |
COMPLETED SUICIDE |
2 |
0.0000 |
| 947 |
CEREBROVASCULAR ACCIDENT |
4 |
0.0000 |
| 948 |
LOSS OF CONSCIOUSNESS |
3 |
0.0000 |
| 949 |
HYPERHIDROSIS |
3 |
0.0000 |
| 950 |
DEVICE DISLOCATION |
1 |
0.0000 |
| 951 |
NO ADVERSE EVENT |
4 |
0.0000 |
| 952 |
INCORRECT DOSE ADMINISTERED |
5 |
0.0000 |
| 953 |
ARTHRALGIA |
9 |
0.0000 |
| 954 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 955 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 956 |
CARDIAC DISORDER |
2 |
0.0000 |
| 957 |
BLOOD GLUCOSE INCREASED |
4 |
0.0000 |
| 958 |
COMA |
1 |
0.0000 |
| 959 |
FLUSHING |
2 |
0.0000 |
| 960 |
FLUID RETENTION |
1 |
0.0000 |
| 961 |
HOSPITALISATION |
3 |
0.0000 |
| 962 |
DEPRESSED MOOD |
1 |
0.0000 |
| 963 |
DRUG DEPENDENCE |
3 |
0.0000 |
| 964 |
ABDOMINAL DISCOMFORT |
3 |
0.0000 |
| 965 |
LETHARGY |
1 |
0.0000 |
| 966 |
MUSCLE SPASMS |
3 |
0.0000 |
| 967 |
FEELING HOT |
1 |
0.0000 |
| 968 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 969 |
AMNESIA |
1 |
0.0000 |
| 970 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 971 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 972 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 973 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 974 |
MOBILITY DECREASED |
1 |
0.0000 |
| 975 |
OVERDOSE |
3 |
0.0000 |
| 976 |
DIABETES MELLITUS |
1 |
0.0000 |
| 977 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 978 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 979 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 980 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 981 |
DRUG DOSE OMISSION |
2 |
0.0000 |
| 982 |
DRUG ABUSE |
1 |
0.0000 |
| 983 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 984 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
2 |
0.0000 |
| 985 |
BREAST CANCER |
1 |
0.0000 |
| 986 |
ILLNESS |
1 |
0.0000 |
| 987 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 988 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 989 |
FEELING ABNORMAL |
1 |
0.0000 |
| 990 |
INJECTION SITE PAIN |
1 |
0.0000 |